A new study suggests that combining two experimental anticancer peptide agents might simultaneously block formation of new tumour blood vessels while also inhibiting the growth of tumour…
An analysis conducted by Ohio State University cancer researchers has found that adding the targeted therapy bevacizumab to the treatment of patients with advanced ovarian cancer is…
New research has identified a small subset of normal white blood cells in the body that gives rise to a rare incurable form of leukaemia…
New research shows that a less-toxic combination of a targeted immune-based drug and a chemotherapy drug can produce long-term remissions in some chronic lymphocytic leukaemia patients.…
A study shows for the first time that the three most common chromosome changes seen in chronic lymphocytic leukaemia disrupt a molecular network that includes several important genes…
New research shows that oncolytic viruses, which are engineered to destroy cancer cells, might be more effective in treating deadly brain tumours if equipped with an enzyme that helps…
A new study by Ohio State University cancer researchers provides a rational for treating breast cancer by combining two kinds of targeted agents, one that inhibits an overactive, cancer-causing…
A new study suggests that the presence of tumour cells in the circulating blood of patients with squamous cell cancer of the head and neck may predict disease recurrence and reduced…
The genes we possess not only determine the colour of our eyes and hair and how our bodies grow, they might also influence the changes that occur in tumours when we develop cancer…
A new study led by Ohio State University cancer researchers describes a novel cancer-specific protein that is present in a broad range of cancer types and at all stages of tumour development,…